403 related articles for article (PubMed ID: 31037146)
41. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
[TBL] [Abstract][Full Text] [Related]
42. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.
Conde J; Tian F; Hernández Y; Bao C; Cui D; Janssen KP; Ibarra MR; Baptista PV; Stoeger T; de la Fuente JM
Biomaterials; 2013 Oct; 34(31):7744-53. PubMed ID: 23850099
[TBL] [Abstract][Full Text] [Related]
43. A novel gold-based stimuli-responsive theranostic nanomedicine for chemo-photothermal therapy of solid tumors.
Mahmoodzadeh F; Abbasian M; Jaymand M; Salehi R; Bagherzadeh-Khajehmarjan E
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():880-889. PubMed ID: 30274125
[TBL] [Abstract][Full Text] [Related]
44. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
[TBL] [Abstract][Full Text] [Related]
45. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
[TBL] [Abstract][Full Text] [Related]
46. Rod-shaped gold nanoparticles biosynthesized using Pb
Qu Y; Lian S; Shen W; Li Z; Yang J; Zhang H
Bioprocess Biosyst Eng; 2020 Jan; 43(1):123-131. PubMed ID: 31628532
[TBL] [Abstract][Full Text] [Related]
47. GE11-PDA-Pt@USPIOs nano-formulation for relief of tumor hypoxia and MRI/PAI-guided tumor radio-chemotherapy.
Yang C; Mi X; Su H; Yang J; Gu Y; Zhang L; Sun W; Liang X; Zhang C
Biomater Sci; 2019 Apr; 7(5):2076-2090. PubMed ID: 30860522
[TBL] [Abstract][Full Text] [Related]
48. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
[TBL] [Abstract][Full Text] [Related]
49. Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts.
Cui L; Her S; Dunne M; Borst GR; De Souza R; Bristow RG; Jaffray DA; Allen C
Radiat Res; 2017 Feb; 187(2):147-160. PubMed ID: 28085639
[TBL] [Abstract][Full Text] [Related]
50. Gold nanoparticles loaded into polymeric hydrogel for wound healing in rats: Effect of nanoparticles' shape and surface modification.
Mahmoud NN; Hikmat S; Abu Ghith D; Hajeer M; Hamadneh L; Qattan D; Khalil EA
Int J Pharm; 2019 Jun; 565():174-186. PubMed ID: 31075436
[TBL] [Abstract][Full Text] [Related]
51. Polymer decorated gold nanoparticles in nanomedicine conjugates.
Capek I
Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
[TBL] [Abstract][Full Text] [Related]
52. Improving
Le Goas M; Paquet M; Paquirissamy A; Guglielmi J; Compin C; Thariat J; Vassaux G; Geertsen V; Humbert O; Renault JP; Carrot G; Pourcher T; Cambien B
Int J Nanomedicine; 2019; 14():7933-7946. PubMed ID: 31686819
[TBL] [Abstract][Full Text] [Related]
53. Stellate Plasmonic Exosomes for Penetrative Targeting Tumor NIR-II Thermo-Radiotherapy.
Zhu D; Lyu M; Huang Q; Suo M; Liu Y; Jiang W; Duo Y; Fan K
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36928-36937. PubMed ID: 32814380
[TBL] [Abstract][Full Text] [Related]
54. Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
Mangadlao JD; Wang X; McCleese C; Escamilla M; Ramamurthy G; Wang Z; Govande M; Basilion JP; Burda C
ACS Nano; 2018 Apr; 12(4):3714-3725. PubMed ID: 29641905
[TBL] [Abstract][Full Text] [Related]
55. Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors.
Hu Y; Li J; Yang J; Wei P; Luo Y; Ding L; Sun W; Zhang G; Shi X; Shen M
Biomater Sci; 2015 May; 3(5):721-32. PubMed ID: 26222591
[TBL] [Abstract][Full Text] [Related]
56. Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.
Liu X; Li H; Chen Y; Jin Q; Ren K; Ji J
Adv Healthc Mater; 2014 Sep; 3(9):1439-47. PubMed ID: 24550205
[TBL] [Abstract][Full Text] [Related]
57. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.
Liang Y; Li S; Wang X; He B; He B; Dai W; Zhang H; Wang X; Wang Y; Zhou D; Zhang Q
Theranostics; 2017; 7(13):3306-3318. PubMed ID: 28900511
[TBL] [Abstract][Full Text] [Related]
58. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
[TBL] [Abstract][Full Text] [Related]
59. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice.
Lin Z; Monteiro-Riviere NA; Riviere JE
Nanotoxicology; 2016; 10(2):162-72. PubMed ID: 25961857
[TBL] [Abstract][Full Text] [Related]
60. In Vivo Characterization of 4
Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
